<DOC>
	<DOCNO>NCT02121002</DOCNO>
	<brief_summary>To establish therapeutic equivalence safety generic Diclofenac Sodium Topical Gel , 1 % Voltaren® Gel 1 % subject osteoarthritis knee .</brief_summary>
	<brief_title>Study Comparing Generic Diclofenac Sodium Topical Gel , 1 % Voltaren Treatment Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Healthy , ambulatory male nonpregnant female subject age ≥ 35 year clinical diagnosis OA knee . Had Xray target knee , take 1 year baseline , show evidence OA KellgrenLawrence grade 13 disease . After discontinue pain medication least 7 day , least moderate pain movement target knee If female childbearing potential , agree abstain sexual intercourse use reliable method contraception study Able tolerate rescue medication paracetamol/acetaminophen . Pregnant lactate plan become pregnant study period . Xray show evidence OA KellgrenLawrence grade 4 disease . History OA pain contralateral knee require medication within 1 year prior screening . After discontinue pain medication least 7 day , baseline score ≥20 mm 0100 mm Visual Analog Scale ( VAS ) contralateral knee immediately prior randomization . History secondary OA , rheumatoid arthritis , chronic inflammatory disease fibromyalgia . History asthma , hypertension , myocardial infarction , thrombotic event , stroke , congestive heart failure , impaired renal function liver disease . History gastrointestinal bleeding peptic ulcer disease . Use warfarin anticoagulant therapy within 30 day study randomization . Elevated transaminase screen . Use ACE inhibitor , cyclosporine , diuretic , lithium methotrexate , within 30 day study randomization . Concomitant use corticosteroid use within 30 day study randomization . Concomitant acetylsalicylic acid therapy stable low dose use cardiac prophylaxis take least 3 month prior enrollment maintain throughout duration study . Known allergy aspirin nonsteroidal antiinflammatory drug Any acute chronic illness could compromise integrity study data place subject risk participate study . Receipt drug part research study within 30 day prior screen . Previous participation study . Any use screen baseline treatment medication may potentially confound study assessment may potentially confound study assessment ( e.g . use topical analgesic antiinflammatory drug ) . Recent history major knee injury surgery . Known history positive HIV</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Knee</keyword>
</DOC>